Pharmafile Logo
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • - PMLiVE
  • Communiqué 53 Cover Image

Ig-Innovations

Ig-Innovations Ltd is a brand new company with over 30 years experience in antibody production and immunoassay development. Confusing but true – the experience and expertise is in the people we employ not the name we give the company. Born-out of the acquisition of the diagnostics division of MicroPharm, Ig has captured the skills and expertise developed during the research and development of sheep derived polyclonal antibodies for human therapy (now FDA & MHRA licensed products), diagnostics and research.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

No items found

Company Details

Ig-Innovations
Gernos, Maesllyn, Llandysul, SA44 5LP
+44 (0)1239 858972
Contact Ig-Innovations
Website

 Latest Content from PMHub 

How to unlock the value of congress: strategies to expand reach, learning and clinical application

Press Releases | May 30, 2024 | EPG Health

Medical congresses are pivotal landmarks in the healthcare calendar. But is their value as a source of the latest and most cutting-edge scientific information being leveraged to its full potential,...

The Power of Patient Insights to Improve Cancer Care

Press Releases | May 30, 2024 | Medscape Education

Two global patient advocacy groups—The Lymphoma Coalition and Lung Cancer Europe— are compiling data from their communities on the real-world experience of living with cancer. What the data reveals sometimes...

Medscape Education Continues Its Patient-Centric Mission at EHA 2024

Press Releases | May 29, 2024 | Medscape Education

Anticipation is building at Medscape Education as the team prepares for the EHA 2024 Congress. Medscape Education is excited to announce a significant presence during the congress including a Medscape...

PM360 – The Importance of Omnichannel Approach for European Physicians

White Papers and Resources | May 28, 2024 | CMI Media Group

Going beyond the sales rep to NPP channels is becoming critical in Europe, as this new PM360 article by our Director of Global Media Matt Durham, details. Read the article here. 

Global Health Beat – Spain

Videos and Podcasts | May 28, 2024 | CMI Media Group

On the Global Health Beat, Matthew Durham, our Director of Global Media; Juan Pedro Franco, General Director, Fidia Pharmaceuticals, and Fernando Rojas, Director Health and Life Sciences, SNGULAR, capture the...

PM360 – A Year in Review

White Papers and Resources | May 28, 2024 | CMI Media Group

It’s been a little over a year since we expanded globally, and in a new article for PM360, Matt Durham, Director, Global Media, shares the insights from that experience –...

PM360 – Transitioning to Omnidynamic in Europe

White Papers and Resources | May 28, 2024 | CMI Media Group

Omnichannel marketing has been adopted in the US but is needed in the EU as well, as this new article by our Global Media Director Matt Durham shares. Read more here!

Financial Times – Doceree Launches HIEP to Unveil the Untapped Potential of Healthcare Digital Platforms

Press Releases | May 28, 2024 | CMI Media Group

As seen in the Financial Times, Doceree, the leading global healthcare marketing platform building unprecedented programmatic solutions for HCP marketing, announced the launch of its highly anticipated HIEP (High Interaction & Engagement...

Fierce Pharma – Study Unveils Top Channel for Engaging HCPs in Europe

White Papers and Resources | May 28, 2024 | CMI Media Group

Read the story here!

CMI Media Group Expands Globally with London Office; Hires Matt Durham as Global Director

Press Releases | May 28, 2024 | CMI Media Group

CMI Media Group Expands Globally with London Office; Hires Matt Durham as Global Director